Patents by Inventor Jasmine Zunic

Jasmine Zunic has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • VLA-4 antagonists
    Patent number: 7514409
    Abstract: Compounds of Formula I are antagonists of VLA-4, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be formulated into pharmaceutical compositions and are suitable for use in the treatment of inflammatory bowel disease including ulcerative colitis and Crohn's disease, multiple sclerosis, asthma, and rheumatoid arthritis.
    Type: Grant
    Filed: March 7, 2005
    Date of Patent: April 7, 2009
    Assignee: Merck & Co., Inc.
    Inventors: William K. Hagmann, Linus S. Lin, Ping Liu, Richard A. Mumford, Thomas S. Reger, Nicholas D. Smith, Nicholas S. Stock, Jasmine Zunic
  • 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS
    Publication number: 20070219206
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.
    Type: Application
    Filed: May 4, 2007
    Publication date: September 20, 2007
    Applicant: AMIRA PHARMACEUTICALS, INC.
    Inventors: John Hutchinson, Petpiboon Prasit, Mark Moran, Jillian Evans, Brian Stearns, Jeffrey Roppe, Bowei Wang, Yen Truong, Yiwei Li, Jasmine Zunic, Jeannie Arruda, Nicholas Stock, Mustapha Haddach, Thomas Seiders, Jill Scott
  • Vla-4 antagonists
    Publication number: 20070179190
    Abstract: Compounds of Formula I are antagonists of VLA-4, and as such are useful in the inhibition or prevention of cell adhesion and cell-adhesion mediated pathologies. These compounds may be formulated into pharmaceutical compositions and are suitable for use in the treatment of inflammatory bowel disease including ulcerative colitis and Crohn's disease, multiple sclerosis, asthma, and rheumatoid arthritis.
    Type: Application
    Filed: March 7, 2005
    Publication date: August 2, 2007
    Applicant: MERCK & CO., INC.
    Inventors: William Hagmann, Linus Lin, Ping Liu, Richard Mumford, Thomas Reger, Nicholas Smith, Nicholas Stock, Jasmine Zunic
  • 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS
    Publication number: 20070123522
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.
    Type: Application
    Filed: October 4, 2006
    Publication date: May 31, 2007
    Applicant: Amira Pharmaceuticals, Inc.
    Inventors: John Hutchinson, Petpiboon Prasit, Mark Moran, Jillian Evans, Jasmine Zunic, Nicholas Stock
  • 5-LIPOXYGENASE-ACTIVATING PROTEIN (FLAP) INHIBITORS
    Publication number: 20070105866
    Abstract: Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of 5-lipoxygenase-activating protein (FLAP). Also described herein are methods of using such FLAP modulators, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other leukotriene-dependent or leukotriene mediated conditions or diseases.
    Type: Application
    Filed: October 27, 2006
    Publication date: May 10, 2007
    Applicant: Amira Pharmaceuticals, Inc.
    Inventors: John Hutchinson, Petpiboon Prasit, Mark Moran, Jillian Evans, Yiwei Li, Jasmine Zunic, Jeannie Arruda, Nicholas Stock, Brian Stearns, Mustapha Haddach, Jeffrey Roppe